Technology to detect preeclampsia in pregnancy

An Irish biotech startup company will join forces with the Mayo Clinic in the United States to licence and develop a technology to detect preeclampsia in pregnancy.

Preeclampsia, affects around three million mothers worldwide every year and is associated with premature births and infant illness including cerebral palsy, blindness and epilepsy.

Inform Bioscience, are set to sign a license agreement with the American medical clinic, which also includes the Biomedical Diagnostics Institute at DCU and is supported by Enterprise Ireland.

It plans to develop a simple urine test which it says has the potential to revolutionise prenatal care programs globally.

More in this Section

Legislation planned to protect long-term renters from eviction

Family of man missing on Everest launch fundraising campaign

Less than half of litter fines paid, report finds

‘Limited’ increases could damage Defence Forces morale


Review: Murder of Garcia Lorca gives backdrop to chilling tale

Harris returns 20 years later to magical characters of ‘Chocolat’

Michelle Darmody: Baking with herbs

Product Watch: Skincare acids not as scary as they seem

More From The Irish Examiner